Introduction
In¯ammation of the bladder is a common disease mainly affecting women. Patients may complain of suprapubic pain, urinary frequency and urgency with or without haematuria on repeated occasions. In many cases, urine analysis reveals white and red blood cells, while a positive bacteriological culture will con®rm an infectious cause of the cystitis. However, if the culture is negative, with or without cells, interstitial cystitis (IC) should be suspected. IC is a poorly understood syndrome that, like bacterial cystitis, occurs primarily in women. Lack of awareness of IC by the physician or the use of an inappropriate diagnostic approach may result in a lengthy period for many patients between the onset of symptoms and diagnosis of IC.
IC is a chronic in¯ammatory bladder disorder of unknown aetiology. Bladder histology, showing in®l-trates of mast cells, eosinophilic leukocytes and T lymphocytes, suggests that the disease is mediated by the immune system. The clinical association of IC with thyroid disorders and systemic autoimmune diseases such as systemic lupus erythematosus [1] and Sjo Ègren's syndrome [2] , has led to the hypothesis that IC may be an autoimmune disease of the bladder. However, the triggering factor that leads to disease is still unknown, as is the case with the associated autoimmune diseases. The most prevalent aetiological theories of IC are: ' Increased permeability of the bladder epithelium, caused by de®cient glycoproteins and glycosaminoglycans (GAGs) of the glycocalyx, allowing urine components to damage the bladder wall. ' Mast cell activation and degranulation by speci®c (IgE binding) or nonspeci®c (e.g. drugs, hormones, acetylcholine) stimuli, leading to the release of pre-stored (e.g. histamine, heparin, tryptase) or de novo produced (e.g. leukotrienes, PGs, thromboxanes) mediators of in¯ammation.
' In®ltration of the bladder wall, induced by unknown stimuli, with lymphocytes, plasma cells, neutrophilic and eosinophilic granulocytes, and mast cells (= in¯ammation).
' Toxic urine components ' Occult infection ' Increased nerve ®bre density However, none of these factors is suf®ciently substantiated by experimental or clinical evidence.
In this review we present published immunological data on the aetiology and pathogenesis, and a novel hypothesis of how IC may be caused, based on our recent ®nding of an association between IC and Sjo Ègren's syndrome.
De®nition
There is no clear de®nition of IC as the clinical symptoms and histology are not speci®c. The diagnosis is essentially a syndrome diagnosis that can only be based on the combination of chronic irritative voiding symptoms, sterile and cytologically negative urine, characteristic cystoscopic ®ndings and the exclusion of other diseases [3] . The diagnosis of IC requires a thorough patient history, cystoscopy carried out under anaesthesia with hydrodistension of the bladder and deep bladder biopsies.
IC primarily occurs in women (80±85%) and typical symptoms consist of urinary frequency, urgency, nocturia and pain in the lower abdominal region. The pain is often associated with bladder ®lling and relieved by urination. Many patients have periods of remission and exacerbation, and the condition is chronic. Symptoms may worsen perimenstrually in about half of the affected women. Cystoscopically, IC is characterized by petechial bladder mucosal haemorrhages (`glomerulations'). Severe IC is associated with reduced bladder capacity and in rare cases with the classic Hunner's ulcer.
There is no consensus about the need for a bladder biopsy for the diagnosis of IC. However, in recent years deep bladder biopsies have been considered essential for the diagnosis as they exclude other bladder diseases, e.g. carcinoma and tuberculosis, while con®rming the histological abnormalities of IC.
Epidemiology
It is not surprising that it is dif®cult to reliably assess the prevalence and incidence of a disease for which the diagnosis is not ®rmly de®ned. There are consequently few published epidemiological studies and the results are variable. In a Finnish study the prevalence was 18.1 per 100 000 in women and 10.6 per 100 000 in the whole population, with an annual incidence of 1.2 cases per 100 000 [4] . In the Netherlands, Bade et al. [5] calculated a prevalence of 8±16 cases in 100 000 women. A recent study in the USA showed a much higher prevalence of 52±67 cases per 100 000 women [6] .
Pathology
On the basis of cystoscopic appearance, two types of IC are generally recognized: the classic ulcerated type and the early un-ulcerated type. Johansson and Fall analysed 210 patients, 146 with an ulcer type and 64 with no ulcers; the mean age of the ulcer group was 57 years and of the second group 38 years, suggesting that the latter type may be an early manifestation of IC [7] .
The pathology of the second type showed suburothelial haemorrhages corresponding to glomerulations in 90% of the patients, while mucosal ruptures were seen in 83%. Overall, most showed only mild in¯ammatory changes, but oedema and dilated vessels were frequently seen.
In the ulcer type, in¯ammatory changes were limited to the lamina propria in < 90% of the patients. Signi®cant detrusor muscle ®brosis was seen in only 10% of the patients. Ulcerations were usually wedgeshaped, extended down to the lamina propria and were generally not deeper than the level of the muscularis mucosae. The urothelium was either absent or¯oating above the surface.
The in¯ammatory in®ltrate seen in IC is predominantly composed of T lymphocytes, with more plasma cells as the degree of in¯ammation increases [8±10]. Submucosal in¯ammation is associated with denuded epithelium, ulceration and pyuria. Epithelial and basement membrane thickness, submucosal oedema, vascular ectasia, ®brosis, and detrusor muscle in¯ammation and ®brosis may also occur but are not speci®c for IC [11] . An increase has been found in the numbers of macrophages, activated lymphocytes and vascular endothelial cells expressing HLA class II molecules within the submucosa [12] .
The diagnostic value of mast cell counts is a subject of controversy. Larsen et al. [13] found a highly signi®cant increase in the number of mast cells within the detrusor muscle bundles in patients with IC. Lynes et al. [14] found a strong relationship between detrusor mast cell density, especially degranulated, and the degree of epithelial loss, submucosal in¯ammation, epithelial ulceration, urinary pyuria and response to treatment. However, recent studies indicated that mast cell counts are not useful in the evaluation of IC and do not allow inclusion or exclusion of a diagnosis of IC. Furthermore, an ultrastructural analysis of all tissue components did not support a primary pathogenetic role of mast cells or a selectively de®cient GAG layer [15, 16] Epithelial cells of lesional and uninvolved bladder tissue usually stain positively for IgA, which may be focal or may diffusely involve all layers of the epithelium. Staining for IgE correlates with the presence of mast cells and is seen in < 2% of cases, also suggesting that mast cells have no prominent role in the pathogenesis of the disease. Eosinophil density in bladder biopsies was uniformly low and similar in IC and control patients. Lynes et al. [14] found no evidence of a relationship between the eosinophil and the in¯ammatory process of IC.
Electron microscopy shows a widening of the interstitium between urothelial cells [17] . Elbadawi and Light [16] found a distinctive combination of peculiar muscle cell pro®les, injury of intrinsic vessels and nerves in the muscularis and suburothelium. A dis-cohesive urothelium was observed in lesional and less markedly in non-lesional bladder samples. Marked oedema of various tissue elements and cells appeared to be common. Urothelial changes disrupted the permeability barrier. Vascular lesions included endothelial cell injury and suggested a slow microcirculation. Neural changes included a combination of degenerative and regenerative features.
It can be concluded from these data that the pathological ®ndings in IC indicate no speci®c causal mechanism, but mainly re¯ect the chronic in¯ammatory nature of the disease.
Aetiology and pathogenesis

Aetiology
The aetiology of IC is unknown and, as in other diseases with no known cause, many theories have been published. IC has been suggested to be of an autoimmune, allergic, infectious, neurological, vascular or mechanical nature, or caused by in®ltration and damage of the bladder wall by activated mast cells, and/or an altered bladder lining permitting entry of allergenic or toxic substances into the underlying tissues [18, 19] . Using an rDNA bacterial PCR to study bladder biopsies and sterile urine samples from patients with IC, Haarala et al. [20] excluded an ongoing bacterial infection as the cause of IC.
The role of mast cells in the bladder wall of IC is highly controversial. The increase in the number of mast cells is not speci®c for IC as it occurs in many other (chronic) bladder diseases. Ultrastructural studies also failed to support a primary pathogenetic role of mast cells, but a leaky urothelium and mast cell activation may be a result of a self-perpetuating process of neurogenic in¯ammation [16] .
IC is not an organ-speci®c disease as many patients have systemic symptoms and blood abnormalities (see below), suggesting that IC may be a local expression of a generalized disease. The association of IC with systemic lupus erythematosus has been known for a long time, with a 30-fold increased risk, and this magnitude of increased risk was also found with Sjo Ègren's syndrome [2] . Furthermore, a recent study revealed a 100-fold increase of in¯ammatory bowel disease (Crohn's disease and ulcerative colitis) in patients with IC [21] . The arguments in favour of an autoimmune nature of IC are:
' IC occurs more frequently in women than in men ' no microorganism or other cause has been found in IC ' IC is frequently associated with arthritis, systemic lupus erythematosus, thyroid disorders and Sjo Ègren's syndrome ' IC is often accompanied by joint pain, muscle pain, fatigue, intestinal disorders and medicine intolerance ' blood tests often show abnormalities such as increased IgG, decreased C4, antinuclear antibodies (ANA) and antibodies to mitochondria and parietal cells ' mainly CD4+ T lymphocytes are found in the in¯amed bladder wall of patients with IC.
Pathogenesis
Several studies have shown abnormalities in IC that may play a role in the pathogenesis of the disease. A small peptide that inhibits the proliferation of normal bladder epithelial cells in vitro has been detected in the urine of 86% of patients with IC, in 12% of women with bacterial cystitis and in 8% of normal control subjects [22] . This antiproliferative factor was subsequently found to originate from the distal ureter or urinary bladder [23] .
The factor needs to be identi®ed to fully understand its relevance and origin in IC. Diffusion of urinary potassium into the bladder interstitium induces sensory symptoms and damages tissue in IC [24] . This may be important in patients with coexisting Sjo Ègren's syndrome, as distal renal tubular acidosis with increased urinary potassium excretion is common in the latter disease.
Bade et al. [25] showed the presence of IgG autoantibodies against bladder epithelium and muscle ®bres in all of three patients with IC who were tested. The chronic lymphocytic in®ltrate probably causes bladder ®brosis as this relationship is also seen in other diseases, e.g. Crohn's disease and sarcoidosis.
Immunology
Blood abnormalities
Sera from patients with IC showed signi®cant depletion of complement C4 and markedly elevated IgG levels [26] , suggesting activation of the classic complement pathway by (auto)antibodies. Studies on peripheral blood lymphocyte subsets showed increased numbers of B lymphocytes and activated lymphocytes [2, 27] , or were found to be entirely normal [8] . Antinuclear antibodies (ANA) at titres of o 1 : 40 have been found in 36±60% of patients with IC [2, 28] . However, these abnormalities are not speci®c and are seen in other chronic in¯ammatory diseases with immunologically mediated tissue damage.
Urine abnormalities
Thirty-three urine specimens from 14 patients with IC showed acute in¯ammation, predominantly polymorphonuclear cells; 14 (42%) specimens contained eosinophils and 10 (30%) contained cells resembling mast cells. Other ®ndings included numerous degenerated cells, reactive transitional cells and haematuria [29] . Levels of tryptase, a mast cell-derived enzyme in 24 h urine samples, but not in`spot' urine samples, are much higher in patients with IC [19] .
Systemic clinical features
Van de Merwe et al. [2] investigated 10 patients with IC for the presence of systemic autoimmune diseases, in particular for Sjo Ègren's syndrome, which is diagnosed on the basis of coexisting involvement of lachrymal and salivary glands, leading to keratoconjunctivitis sicca (KCS) and focal lymphocytic sialadenitis (FLS), respectively. Other features consist of arthralgia and disabling fatigue in 80% of the patients. Serological abnormalities include antinuclear antibodies, rheumatoid factors and antibodies to SS-A/Ro and SS-B/La. In two patients both KCS and FLS were present, thus diagnosing Sjo Ègren's syndrome. Additionally, in six patients one of these two features was present; KCS in three and FLS in three. Unpublished data (van de Merwe, Arendsen and Hooijkaas) of a preliminary analysis of 80 patients with IC showed that 14% also had Sjo Ègren's syndrome, 26% KCS and 5% FLS.
Alagiri et al. [21] conducted a questionnaire-based study evaluating 12 disease processes and surveying the characteristics of IC in a population of 2405 individuals with IC who responded to the initial survey; an additional 277 individuals were randomly selected and individually contacted. Compared with the general population, individuals with IC were 100 times more likely to have in¯ammatory bowel disease (7.3%, population 0.07%) and 30±50 times more likely to have systemic lupus erythematosus (1.7%, population 0.05%). In addition, there were increased frequencies of allergies (40.6%; population 22.5%), irritable bowel syndrome (25.4%, population 2.9%), sensitive skin (22.6%, population 10.6%), and ®bromyalgia (12.8%, population 3.2%) [21, 30] in patients with IC.
Hypothesis
If it is true that IC, systemic lupus erythematosus and Sjo Ègren's syndrome are all expressions of a comparable disturbed immunological mechanism, recent and intriguing ®ndings in Sjo Ègren's syndrome may be relevant for IC. Sjo Ègren's syndrome is an autoimmune exocrinopathy with general mucosal dryness and systemic symptoms. Histologically it is characterized by periductal focal in®ltration of exocrine glands with mainly T lymphocytes. In patients and animal models the in®ltration of exocrine glands does not fully explain the lack of secretory function of the glands. Additionally, autoantibodies to the acetylcholine receptors, e.g. the muscarinic M 3 -receptors, in salivary and lachrymal glands can functionally block these receptors [31, 32] . This can partly be overcome by muscarinic agonists such as pilocarpine hydrochloride [33, 34] . Autoantibodies to the muscarinic M 1 -receptor have also been detected in patients with Sjo Ègren's syndrome [35] . Myasthenia gravis, an autoimmune disease also associated with Sjo Ègren's syndrome and systemic lupus erythematosus, is mediated by autoantibodies to the nicotinic acetylcholine receptor at the surface of striated muscles [36] . Studies on Graves' disease have clearly shown that antibodies to the thyroid-stimulating hormone receptor may stimulate or block receptor functions, or even show alternating stimulation and blocking in time within the same patients [37] .
The human detrusor smooth muscle is endowed with muscarinic M 1 -, M 2 -, and M 3 -receptors, with direct and indirect effects on smooth muscle contraction [38, 39] . Furthermore, carbachol, a muscarinic receptor agonist, has been found to trigger serotonin release from rat bladder mast cells in a dose-dependent manner, an effect increased by pre-treating tissue with oestradiol, and that is blocked by atropine [40] . Recently, IgG autoantibodies against epithelium and muscle ®bres were found in patients with IC [25] .
Stimulating and/or blocking autoantibodies to various subtypes of muscarinic receptors could theoretically be responsible for both exocrine dysfunction and detrusor smooth muscle contractions. It is well known that antibodies can attract in¯ammatory cells to the sites of their antigen binding as a consequence of the activation of complement proteins, with the release of chemotactic fragments. The observation that in¯ammatory in®ltrates are mainly seen in late stages of the disease [7] is in line with this hypothesis.
Summary
IC is a complex syndrome consisting of urinary voiding symptoms, lower abdominal pain and signs of chronic in¯ammation at cystoscopy and pathology. The cause of the disease is unknown but the in®ltration of the bladder wall by mainly T lymphocytes in addition to mast cells, the occurrence of autoantibodies in many patients and the association with systemic autoimmune diseases suggest an autoimmune nature of the disease.
The strong association of IC with Sjo Ègren's syndrome warrants the exploration of comparable mechanisms in both diseases. Recent data on Sjo Ègren's syndrome suggest that initial abnormalities may consist of autoantibodies to the muscarinic M 3 -receptors, causing impaired nervous stimulation of the exocrine glands. In¯ammatory changes may be a late consequence of the binding of these autoantibodies to the receptors. It is postulated that autoantibodies to various subtypes of muscarinic receptors on detrusor smooth muscle could theoretically explain initial voiding symptoms and late in¯ammatory changes in the bladder in IC and the association of IC with Sjo Ègren's syndrome.
